At the beginning of the week before the official opening of CPHI Frankfurt 2025, SGD Pharma had the pleasure to welcome its Agents and Distributors from across Europe, the Middle East, and Africa for an inspiring pre-show meeting.
This gathering was the perfect opportunity to:
- Share our latest strategic updates and the 2026–2027 roadmap
- Present our recent product portfolio extensions
- Introduce the Transform & Grow program, led by Alexandre Le Chippey and his team, designed to boost sales performance and strengthen partnerships throughout the EMEA region.
We also took this moment to renew our collective ambition for growth and proudly unveil the rebranding of SGD Pharma’s product lines, a key milestone in our transformation journey.
Beyond the presentations, this pre-show was above all a great moment to connect, align, and get ready for CPHI as One Team!
🌍 Boost growth with innovation
🤝 Foster business development
💚 Grow together for the patient’s benefit
A heartfelt thank you to all contributors who made this meaningful session possible:
Alexandre Le Chippey, Frédéric de Keréver, Fabio Invernizzi - Change Management, Fabrice Gautier, Fabio Rossi, Natallia Dzeikala, Najet Mebarki , Andrea Cecchetto, Annalisa G., Claudia Albanese, Aline Baillet
-
- À propos
- Actualités
- Carrière
- Produits & Innovations
- Ampoules
- Flacons de Type I
- Flacons injectables
- Perfusions
- Oral
- Nasal
- Healthcare
- Beauty & Care
- SGD Pharma +
- Media center
- Contactez-nous
-
